Second-line treatment with ifosfamide and carboplatin in patients with ovarian carcinoma relapsing after treatment with carboplatin
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (1) , 30-33
- https://doi.org/10.1016/s0959-8049(05)80013-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Responses to salvage chemotherapy in ovarian cancer: a critical need for precise definitions of the treated population.Journal of Clinical Oncology, 1992
- Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1991
- Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group studyEuropean Journal of Cancer and Clinical Oncology, 1991
- Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.Journal of Clinical Oncology, 1991
- Phase II trial of trimelamol in refractory ovarian cancerBritish Journal of Cancer, 1991
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990
- Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancerCancer Chemotherapy and Pharmacology, 1989
- Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trialsBritish Journal of Cancer, 1989
- Reporting results of cancer treatmentCancer, 1981